Table 6 also showed that a high Ly6H mRNA expression in breast cancer was significantly correlated with decreased five-year recurrence survival (recurrence, n=47 vs recurrence free, n=105) and decreased five-year metastasis free survival (metastasis, n=29 vs metastasis free, n=123) in Desmedt [128] study. The gene discussed is LY6H; the disease is breast carcinoma.